Solid-state characterization of two polymorphic forms of R-albuterol sulfate.
暂无分享,去创建一个
[1] S. Palacios,et al. Validation of a chiral HPLC assay for (R)-salbutamol sulfate. , 2004, Journal of pharmaceutical and biomedical analysis.
[2] David E. Bugay,et al. Physical Characterization of Pharmaceutical Solids , 1995, Pharmaceutical Research.
[3] J. Caldwell,et al. Putting chirality to work: the strategy of chiral switches , 2002, Nature Reviews Drug Discovery.
[4] D. Bugay. Characterization of the solid-state: spectroscopic techniques. , 2001, Advanced drug delivery reviews.
[5] S. Palacios,et al. Resolution of racemic albuterol via diastereomeric salts formation with di-p-toluoyl-D-tartaric acid. , 2000, Enantiomer.
[6] C. Page,et al. Contrasting properties of albuterol stereoisomers. , 1999, The Journal of allergy and clinical immunology.
[7] J. Benovic,et al. Comparison ofR-, S-, andRS-albuterol interaction with human β1 and β2-adrenergic receptors , 1996 .
[8] S. Byrn. Solid state chemistry of drugs , 1982 .
[9] A. Carpy,et al. Structure cristalline du sulfate de salbutamol [tert-butylamino-2 (hydroxy-4 hydroxyméthyl-3 phényl)-1 éthanol.0.5H2SO4] , 1978 .
[10] D. Middlemiss,et al. Absolute configuration of the optical isomers of salbutamol. , 1971, Journal of medicinal chemistry.
[11] W. Mccrone,et al. Pharmaceutical applications of polymorphism. , 1969, Journal of pharmaceutical sciences.